TH174395A - Carbamate compounds and their production and use - Google Patents
Carbamate compounds and their production and useInfo
- Publication number
- TH174395A TH174395A TH1401003901A TH1401003901A TH174395A TH 174395 A TH174395 A TH 174395A TH 1401003901 A TH1401003901 A TH 1401003901A TH 1401003901 A TH1401003901 A TH 1401003901A TH 174395 A TH174395 A TH 174395A
- Authority
- TH
- Thailand
- Prior art keywords
- constituents
- compounds
- pharmaceutical
- production
- abhd6
- Prior art date
Links
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 7
- 239000000470 constituent Substances 0.000 claims abstract 6
- 239000000126 substance Substances 0.000 claims abstract 3
- 102100004952 ABHD6 Human genes 0.000 claims abstract 2
- 101700004370 ABHD6 Proteins 0.000 claims abstract 2
- 102100007223 MGLL Human genes 0.000 claims abstract 2
- 101700027140 MGLL Proteins 0.000 claims abstract 2
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- 208000008589 Obesity Diseases 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 201000011510 cancer Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 238000001647 drug administration Methods 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 235000020824 obesity Nutrition 0.000 claims abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 claims abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 2
- 230000001105 regulatory Effects 0.000 claims abstract 2
Abstract
DC60 (26/09/57) ข้อเปิดเผยการประดิษฐ์นี้ ได้จัดให้มีสารประกอบและองค์ประกอบซึ่งอาจเป็นสารควบคุม MAGL และ/หรือ ABHD6 และการใช้สารดังกล่าวเป็นสารทางด้านยา, กรรมวิธีสำหรับการเตรียม, และองค์ประกอบทางเภสัชกรรม ซึ่งรวมถึงสารประกอบที่ได้เปิดเผยในฐานะสารออกฤทธิ์อย่างน้อย 1 ชนิด ข้อเปิดเผยการประดิษฐ์นี้ ยังได้จัดให้มีวิธีการบำบัดผู้ป่วยที่จำเป็นต้องได้รับการบำบัดโดยที่ ผู้ป่วยประสบปัญหาจากอาการบ่งชี้ อย่างเช่น ความปวด, มะเร็งเนื้องอกชนิดแข็ง และ/หรือ โรคอ้วน ซึ่งประกอบรวมด้วย การบริหารยาของสารประกอบหรือองค์ประกอบที่ได้เปิดเผยตามการประดิษฐ์นี้ สิทธิบัตรยา DC60 (26/09/14) Disclosure of this invention. Prescribing compounds and constituents which may be MAGL and / or ABHD6 regulated substances and their use as pharmaceutical agents, preparations, and pharmaceutical constituents. This includes at least one compound disclosed as an active ingredient. In addition, there are methods for treating patients who need to be treated by Patients experience symptoms such as pain, cancer, hard neoplasms and / or obesity, which include: Drug administration of compounds or constituents disclosed according to this invention; drug patents
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH174395A true TH174395A (en) | 2018-03-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122984T1 (en) | CARBAMIDE COMPOUNDS AND METHODS OF THEIR PREPARATION AND USE | |
| EA202090871A1 (en) | INHIBITION OF UBIKVITIN-SPECIFIC PEPTIDASE 30 | |
| EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
| MX2015012559A (en) | Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases. | |
| EA201790174A1 (en) | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
| MX2015017961A (en) | Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof. | |
| EA201590655A8 (en) | COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| PH12017500493A1 (en) | Combination therapy | |
| MA39725B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
| EA201590654A1 (en) | COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE | |
| EA201400969A1 (en) | NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF PARKINSON'S Disease | |
| MX2015010829A (en) | Therapeutic compounds and uses thereof. | |
| EA201890449A1 (en) | FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
| EA201990400A1 (en) | COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION | |
| EA201691570A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING DIAMINO-HETEROCYCLIC CARBOXAMIDE COMPOUND AS AN ACTIVE INGREDIENT | |
| EA201990399A1 (en) | COMPOUNDS, COMPOSITIONS AND THEIR APPLICATION | |
| MX2019004200A (en) | Combination therapy. | |
| TH174395A (en) | Carbamate compounds and their production and use | |
| TH1901001668A (en) | Indazole compound for use in tendon and/or tendon injuries. | |
| TH152517A (en) | Dipluoro-hexahydro-cyclopentahoxinil and dipluoro-hexahydro-benzooxinil as BACE1 inhibitors. | |
| EA201892675A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ETHEPLIRSEN | |
| TH166182A (en) | "Pharmaceutical mixtures for the prevention or treatment of skin rashes" | |
| TH153174A (en) | Immidazopyridinone Compound | |
| TH161044B (en) | Tri (hetero) eryil pyrazole and its uses | |
| TH158984A (en) | Therapeutic active compounds and their methods of use |